CeptarisCeptaris CompanyCeptaris Investigational DrugCeptaris NewsCeptaris Contact Us  
       
       
   
 
 

 

 


Ceptaris Therapeutics Inc., a privately held, specialty pharmaceutical company, is developing a proprietary formulation of mechlorethamine gel for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma.

Based upon results of a recently completed trial, Ceptaris intends to file a new drug application (NDA) with the Food and Drug Administration (FDA) in 2011. If approved, Ceptaris' investigational drug would be the first topical mechlorethamine product available to treat the signs and symptoms of this rare cancer.

Ceptaris has augmented its management team with the addition of a number of experienced pharmaceutical executives as it approaches regulatory filing and potential commercialization of mechlorethamine gel.
 

 

 

 


PLEASE READ THIS AGREEMENT CAREFULLY BEFORE ACCESSING THIS WEBSITE. BY ACCESSING THIS WEBSITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS BELOW. IF YOU DO NOT WISH TO BE BOUND BY THESE TERMS AND CONDITIONS, YOU MAY NOT ACCESS OR USE THIS WEBSITE.

Ceptaris Therapeutics is working hard to ensure that the information provided on this website is accurate and up-to-date., Ceptaris does not guarantee the accuracy or completeness of the information provided on this website. Ceptaris reserves the right to make changes to the content of this website from time to time without notice to you.

Permission to Browse Website and Limited Permission to Make Copies:
You may browse this website for information and may print copies of its contents for your own use. You must obtain the prior written consent of Ceptaris if you want to incorporate all or some of the contents into your own website or written materials, or create "derivative works." . To obtain Ceptaris' written permission, please send your written request to info@ceptaris.com.

Remember:
Although it may be easy to copy information or websites in cyberspace, this does not mean it is legal to do so.

Copyrights:
The information contained in the website and all copyrights to such information are the property of Ceptaris The owners of any copyrighted information that is the property of third parties and which is included in the Ceptaris website will be stated on the website. Portions of the contents of this website are registered with the Federal Copyright Office. Please familiarize yourself with US and International copyright laws before using any information or contents obtained from this website.

Links to Third Party Websites:
Please understand that when you access another website through this website, Ceptaris accepts no responsibility for your experience with the third party website. In addition, Ceptaris does not endorse or recommend third party websites or their contents including any third party websites which are included by a link in this website.

No Warranties; Limitations of Liability:
Ceptaris assumes no responsibility for errors or omissions on this website. ACCESS TO THIS WEBSITE IS PROVIDED AS IS WITHOUT ANY WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT. Ceptaris is not liable for any special, indirect, incidental, or consequential damages, including without limitation, lost revenues or lost profits, which may result from the use of this website.
 

 

 
   
     
 
   
   
   
   
         
print page